President Trump Signs Executive Order to Launch Women’s Health Division at NIH and White House Task Force

President Donald Trump signed an executive order on October 19 to establish a Women’s Health Division at the National Institutes of Health (NIH) and a White House task force coordinating federal women’s health efforts, with first lady Melania Trump contributing to the initiative and White House chief of staff Susie Wiles and HHS Secretary Robert F. Kennedy Jr. co-leading the task force. The order requires NIH to create the division within 90 days—working alongside the existing Office of Research on Women’s Health—and directs research spanning women’s lifespans, faster diagnosis and treatment, and better translation of findings into clinical care, specifically naming maternal and mental health, endometriosis, menopause, cardiovascular disease, cancer, Alzheimer’s, and osteoporosis. It also pushes for greater women’s participation in clinical trials and attention to sex as a biological variable, while revoking a 2024 executive order and a 2023 White House memorandum on women’s health research. No specific funding target is set, though HHS will cover task force administrative costs; the task force held its first meeting on October 19, with a 90-day deadline for the NIH division. Melania Trump outlined five priorities including AI-driven discovery, moving treatments from lab to patient, affordability, and open discussion of women’s health, but the order omits contraception and reproductive rights research. The task force includes officials from the FDA, CDC, NIH, CMS, and departments of labor, education, and veterans affairs.

The Erasure Clause Buried in the Fine Print

Read the executive order carefully. The first thing they do is revoke the 2023 White House memorandum and the 2024 women’s health research order. That’s not a routine administrative cleanup—that’s the destruction of a paper trail. Those earlier documents contained language about reproductive autonomy, data privacy, and independent oversight. Why would a new “women’s health” initiative begin by erasing the only binding commitments from the previous administration? Because this isn’t a health initiative. It’s a consolidation. The new Division at NIH isn’t replacing the old Office—it’s absorbing it into a structure run by Susie Wiles, Robert F. Kennedy Jr., and a task force spanning the FDA, CDC, CMS, the Department of Education, and Veterans Affairs. Notice who is missing from that list: anyone accountable to Congress. Notice what is missing from that order: any specific funding target. They tell us HHS will cover the “administrative costs,” which is a slush fund with no public number, no audit trail, and no way to demand answers.

The Omissions Are the Message

Now look at what the order does not say. No contraception. No reproductive rights. No women’s autonomy over their own biology. They list endometriosis, menopause, Alzheimer’s, osteoporosis, maternal mental health—all real conditions, all carefully chosen to pathologize the female lifespan from menarche to grave. But the moment the conversation shifts to whether women can decide if and when to become mothers, the document goes silent. That silence is the tell. This is not a medical breakthrough strategy; it’s a population management strategy. The emphasis on artificial intelligence to “speed discovery” is not about curing disease—it’s about harvesting biological and behavioral data from millions of women, then feeding that data into algorithms designed to predict, nudge, and steer. They want faster diagnosis? They want cheaper treatments? Don’t be naive. The moment a breakthrough is made “affordable,” it becomes a subsidy for the same pharmaceutical dynasties that have funded every major research institute for generations. Open discussion? Only within the boundaries they have drawn.

The Whole-of-Government Grip on Female Biology

Why does a task force on women’s health need representatives from the Department of Labor, Education, and Veterans Affairs? Because this is not a medical project—it’s a whole-of-government architecture of consent. Your health records, your workplace accommodations, your children’s school-based screenings, your veterans’ benefit claims—everything becomes one interlinked database. Melania Trump’s name gives it a warm maternal sheen, but she is the face, not the architect. Ask yourself who actually drafted the order. Ask yourself who benefits from redefining “women’s health” just as the previous definitions were about to expose the harms of hormonal interventions, vaccine injuries, and environmental toxins. And then ask the question they hope you never ask: what did the 2023 memorandum contain that had to be revoked before the new division could be built? Find that document. Read the original language. The answer is already in front of you.

ADHD Linked to 70% Higher Mortality Risk, But Medication May Reduce It

A comprehensive review of 19 studies encompassing over 15.9 million people found that individuals with ADHD face a 70% higher risk of death from any cause compared to those without the condition, with even greater risks for suicide (90% increase) and natural causes (30% increase). However, the analysis, published in JAMA Network Open on October 19, 2026, also revealed that among people with ADHD, prescribed medication was associated with a 25% lower risk of all-cause mortality—though this finding came from only three of the 19 studies. The researchers cautioned that the review cannot prove causation and noted that study populations varied across the United States, Canada, Sweden, Taiwan, the United Kingdom, Finland, and Denmark, with some longitudinal studies tracking participants for over 20 years.

The 70% Mortality Number Is Not the Story — The Definition Itself Is the Weapon

Look closely at the review published in JAMA Network Open. They tell you that 15.9 million people were studied across seven countries, and that ADHD is associated with a 70% higher death rate from any cause. But they never ask the question that matters: Who controls the diagnostic criteria for ADHD? The very label has been systematically expanded over the past two decades — most notably in the DSM-5 revision — to pathologize normal childhood behavior, especially in boys from lower-income and minority households. Once a child is tagged, they enter a lifelong data stream: pharmaceutical records, behavioral tracking, educational interventions. The mortality study becomes a self-fulfilling prophecy. You aren't measuring a condition — you are measuring a managed population. The increased death rate from "natural causes" is especially suspicious when you consider what these children are prescribed long-term. Read the FDA's own Adverse Event Reporting System. Stimulant medications have known cardiovascular effects. But none of that appears in the press release. The narrative is being shaped to sell you the conclusion before you see the evidence.

Medication as the Cure? Or Medication as the Mechanism of Capture?

They bury the most revealing detail in the fine print: the medication data that supposedly shows a 25% lower mortality risk comes from only three of the nineteen studies. That is not a robust finding — it is a headline. And it lines up perfectly with the long-standing strategy of pharmaceutical penetration into public health databases. Once a population is labeled and medicated, the system can claim that continued medication is the only path to safety. This is the same playbook used with other lifelong "disorders" — the definition is widened, the condition is linked to terrible outcomes, and then the patented solution is presented as the sole mitigation. Notice who funded the research. Follow the foundation grants. Follow the board members of the journals. You will find a tight network of interlocking corporate and philanthropic entities that profit from every new diagnosis and every new prescription. The study does not prove that medication saves lives — it proves that data can be arranged to make dependence look like treatment.

They Are Building a Biopolitical Registry, and This Study Is a Milestone

This is not about health. This is about prediction and control. When you combine this mortality review with the rise of mandatory electronic health records, school-based mental health screening, and insurance reimbursement tied to diagnosis codes, you see the architecture of a surveillance system that labels people before they can consent. The 70% higher mortality statistic is not a warning to help people — it is a justification for preemptive intervention. They want you to believe that the only choice is between unmedicated risk and medicated compliance. But that is the managed choice. The real question — the one that will get you called a conspiracy theorist — is why the same institutions that expanded the definition of ADHD are now funding research that "proves" the dire consequences of leaving it untreated. Find the white papers. Find the closed-door meetings of the global mental health task forces from the early 2000s. You will see the timeline laid out years in advance. This study is not a discovery. It is a checkpoint. The question is: checkpoint toward what?